Literature DB >> 3060795

Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.

G Riou1, M Barrois, Z M Sheng, P Duvillard, C Lhomme.   

Abstract

The c-Ha-ras-1 locus was analysed in cervical cancers and shown to exhibit the loss of one allele in 36% of heterozygous tumours and a mutation at codon 12 in 24% of tumours at advanced stages. 40% of tumours with mutation contained also a deletion. A c-myc gene activation was found in 100% and 70% of tumours containing mutation and deletion respectively. This suggests that the two proto-oncogenes cooperate for the progression of cervical cancers. Furthermore as more than 90% of these tumours contained also human papillomavirus sequences, our data strongly suggest that multiple genetic events are involved in the genesis and progression of most cervical cancers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060795

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

2.  Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

Authors:  E S Srivatsan; B C Misra; M Venugopalan; S P Wilczynski
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

3.  Population genetics of the HRAS1 minisatellite locus.

Authors:  B Devlin; T Krontiris; N Risch
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

Review 4.  Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

5.  Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.

Authors:  J J O'Leary; R J Landers; I Silva; V Uhlmann; M Crowley; I Healy; K Luttich
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

6.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.

Authors:  P J Hurlin; P Kaur; P P Smith; N Perez-Reyes; R A Blanton; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 7.  A possible role for human papillomaviruses in head and neck cancer.

Authors:  B M Steinberg; T P DiLorenzo
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.

Authors:  M Akasofu; Y Oda
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

Authors:  R F Caduff; C M Johnston; T S Frank
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Characterization of c-Kit expression and activation in KSHV-infected endothelial cells.

Authors:  Janet L Douglas; Jill G Whitford; Ashlee V Moses
Journal:  Virology       Date:  2009-06-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.